Biologics License Application
The latest news about Biologics License Application: headlines, AI summaries and the full story from every source.
- uniQure Receives FDA Priority Review for AMT-130 with PDUFA Date Set for May 2027
- AbbVie Submits FDA Biologics License Application for Etentamig in Multiple Myeloma
- FDA Approves Additional Manufacturing Capacity for Alvotech's Biosimilar Simlandi
- Class Action Lawsuit Filed Against Replimune Group, Inc.
- Class Action Lawsuit Filed Against Replimune Group Following FDA's BLA Denial
- Pomerantz Law Firm Investigates Replimune Group, Inc. for Potential Securities Fraud